| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.055 | 0.8 |